This study is exploring whether proteins in someone's blood (novel plasma biomarkers) that indicate Alzheimer’s disease and neurodegeneration can help to predict cognitive decline in psychosis. It is also looking at whether inflammation is related to this.

Who can take part?

We are looking for people with very late onset psychosis (current or resolved). This means people whose symptoms of psychosis - such as hallucinations and/or delusions - set in after the age of 60.

What does taking part involve?

The first appointment, to confirm the person's consent to take part in the trial, can be at home or in our clinic. 

Then, they will visit the clinic for an interview. We will also take a blood sample. There is an optional DaTSCAN and MRI brain scan. 

Finally, we will follow up again 12 months later, to repeat the interview and take another blood sample. 

(Travel expenses will be covered for visiting the clinic.)

Interested in taking part?

To find out more about the CAP study, please contact victoria.hetherington@cntw.nhs.uk or leigh.townsend@cntw.nhs.uk.